Harvard Bioscience Pre-Tax Profit Margin 2012-2026 | HBIO
Harvard Bioscience pre-tax profit margin from 2012 to 2026. Pre-tax profit margin can be defined as earnings before taxes as a portion of total revenue.
| Harvard Bioscience Pre-Tax Profit Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM Pre-Tax Income | Pre-Tax Margin |
| 2026-03-31 | $0.09B | $-0.01B | -10.47% |
| 2025-12-31 | $0.09B | $-0.06B | -65.52% |
| 2025-09-30 | $0.09B | $-0.05B | -60.23% |
| 2025-06-30 | $0.09B | $-0.06B | -62.92% |
| 2025-03-31 | $0.09B | $-0.06B | -61.96% |
| 2024-12-31 | $0.10B | $-0.01B | -10.53% |
| 2024-09-30 | $0.10B | $-0.01B | -12.24% |
| 2024-06-30 | $0.10B | $-0.01B | -8.91% |
| 2024-03-31 | $0.11B | $-0.01B | -7.48% |
| 2023-12-31 | $0.11B | $0.00B | -2.68% |
| 2023-09-30 | $0.11B | $0.00B | -2.68% |
| 2023-06-30 | $0.11B | $-0.01B | -6.14% |
| 2023-03-31 | $0.11B | $0.00B | -1.75% |
| 2022-12-31 | $0.11B | $-0.01B | -8.85% |
| 2022-09-30 | $0.12B | $-0.01B | -6.78% |
| 2022-06-30 | $0.12B | $0.00B | -2.48% |
| 2022-03-31 | $0.12B | $-0.01B | -5.79% |
| 2021-12-31 | $0.12B | $0.00B | -0.84% |
| 2021-09-30 | $0.12B | $0.00B | -2.56% |
| 2021-06-30 | $0.11B | $0.00B | -3.60% |
| 2021-03-31 | $0.11B | $0.00B | -3.81% |
| 2020-12-31 | $0.10B | $-0.01B | -6.86% |
| 2020-09-30 | $0.10B | $-0.01B | -5.88% |
| 2020-06-30 | $0.11B | $-0.01B | -7.62% |
| 2020-03-31 | $0.11B | $-0.01B | -7.14% |
| 2019-12-31 | $0.12B | $-0.01B | -5.17% |
| 2019-09-30 | $0.12B | $-0.01B | -5.04% |
| 2019-06-30 | $0.12B | $0.00B | -3.31% |
| 2019-03-31 | $0.12B | $-0.01B | -4.07% |
| 2018-12-31 | $0.12B | $-0.01B | -6.56% |
| 2018-09-30 | $0.11B | $-0.01B | -7.27% |
| 2018-06-30 | $0.10B | $-0.01B | -8.00% |
| 2018-03-31 | $0.09B | $-0.01B | -8.05% |
| 2017-12-31 | $0.08B | $0.00B | -3.85% |
| 2017-09-30 | $0.08B | $0.00B | -4.88% |
| 2017-06-30 | $0.09B | $0.00B | -4.55% |
| 2017-03-31 | $0.10B | $0.00B | -4.21% |
| 2016-12-31 | $0.10B | $0.00B | -2.88% |
| 2016-09-30 | $0.11B | $0.00B | -1.89% |
| 2016-06-30 | $0.11B | $0.00B | -1.87% |
| 2016-03-31 | $0.11B | $0.00B | -0.91% |
| 2015-12-31 | $0.11B | $0.00B | -2.75% |
| 2015-09-30 | $0.11B | $0.00B | -1.80% |
| 2015-06-30 | $0.11B | 0 | 0.00% |
| 2015-03-31 | $0.11B | $0.00B | 0.93% |
| 2014-12-31 | $0.11B | $0.00B | 3.70% |
| 2014-09-30 | $0.11B | $0.00B | 1.89% |
| 2014-06-30 | $0.11B | $0.00B | 0.94% |
| 2014-03-31 | $0.11B | 0 | 0.00% |
| 2013-12-31 | $0.11B | 0 | 0.00% |
| 2013-09-30 | $0.11B | $0.01B | 5.71% |
| 2013-06-30 | $0.11B | $0.01B | 5.66% |
| 2013-03-31 | $0.11B | $0.01B | 6.48% |
| 2012-12-31 | $0.11B | $0.01B | 6.36% |
| 2012-09-30 | $0.11B | $0.01B | 4.50% |
| 2012-06-30 | $0.11B | $0.01B | 4.50% |
| 2012-03-31 | $0.11B | $0.01B | 5.45% |
| 2011-12-31 | $0.11B | $0.01B | 6.48% |
| 2011-09-30 | $0.11B | $0.01B | 6.42% |
| 2011-06-30 | $0.11B | $0.01B | 8.26% |
| 2011-03-31 | $0.11B | $0.01B | 8.33% |
| 2010-12-31 | $0.11B | $0.01B | 9.26% |
| 2010-09-30 | $0.11B | $0.01B | 12.26% |
| 2010-06-30 | $0.10B | $0.01B | 11.88% |
| 2010-03-31 | $0.09B | $0.01B | 10.75% |
| 2009-12-31 | $0.09B | $0.01B | 10.47% |
| 2009-09-30 | $0.08B | $0.01B | 7.41% |
| 2009-06-30 | $0.08B | $0.01B | 8.75% |
| 2009-03-31 | $0.09B | $0.01B | 9.41% |
| 2008-12-31 | $0.09B | $0.01B | 9.09% |
| 2008-09-30 | $0.09B | $0.01B | 8.89% |
| 2008-06-30 | $0.09B | $0.01B | 8.99% |
| 2008-03-31 | $0.09B | $0.01B | 11.63% |
| 2007-12-31 | $0.08B | $0.01B | 12.05% |
| 2007-09-30 | $0.08B | $0.01B | 11.25% |
| 2007-06-30 | $0.08B | $0.01B | 11.25% |
| 2007-03-31 | $0.08B | $0.01B | 10.26% |
| 2006-12-31 | $0.08B | $0.01B | 10.53% |
| 2006-09-30 | $0.07B | $0.01B | 11.11% |
| 2006-06-30 | $0.07B | $0.01B | 11.43% |
| 2006-03-31 | $0.07B | $0.01B | 10.29% |
| 2005-12-31 | $0.07B | $0.01B | 8.96% |
| 2005-09-30 | $0.05B | $0.01B | 16.98% |
| 2005-06-30 | $0.05B | $0.01B | 16.98% |
| 2005-03-31 | $0.06B | $0.01B | 13.56% |
| 2004-12-31 | $0.07B | $0.01B | 10.77% |
| 2004-09-30 | $0.09B | $0.01B | 5.88% |
| 2004-06-30 | $0.09B | $0.01B | 5.62% |
| 2004-03-31 | $0.09B | $0.01B | 6.74% |
| 2003-12-31 | $0.09B | $0.01B | 8.14% |
| 2003-09-30 | $0.08B | $0.00B | 3.70% |
| 2003-06-30 | $0.07B | $0.00B | 1.37% |
| 2003-03-31 | $0.07B | $0.00B | 3.08% |
| 2002-12-31 | $0.06B | $0.00B | 3.45% |
| 2002-09-30 | $0.05B | $0.00B | 5.88% |
| 2002-06-30 | $0.05B | $0.00B | 6.12% |
| 2002-03-31 | $0.05B | $0.00B | -8.89% |
| 2001-12-31 | $0.04B | $0.00B | -9.52% |
| 2001-09-30 | $0.04B | $0.00B | 12.82% |
| 2001-06-30 | $0.04B | $-0.01B | -30.56% |
| 2001-03-31 | $0.03B | $-0.07B | -206.06% |
| 2000-12-31 | $0.03B | $-0.07B | -235.48% |
| 2000-09-30 | $0.03B | $-0.07B | -246.67% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Computer and Technology | Scientific Instruments Manufacturing | $0.019B | $0.087B |
| HARVARD BIOSCIENCE develops, manufactures and markets tools used in drug discovery research at pharmaceutical and biotechnology companies, universities and government laboratories. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Bruker (BRKR) | United States | $5.722B | 20.54 |
| Kewaunee Scientific (KEQU) | United States | $0.100B | 8.24 |